Hippo ERcast November 2024

November 2024 Intro: Dirty Little Secrets

Emergency medicine often lives in the gap between evidence-based practice and what actually works on shift. Real-world prescribing, abscess management, and symptom relief all force tradeoffs among trial data, patient adherence, follow-up, and comfort. Evidence Versus Real-World Emergency Care Adherence over ideal dosing: Cephalexin four-times-daily dosing may fit the evidence, but twice-daily 1000 mg dosing reflects a common ED tradeoff when adherence is more realistic than a perfect prescription. Abscess packing habits: Routine abscess packing persists despite randomized data suggesting many cavities do not benefit, partly because training patterns and the built-in follow-up still influence bedside decisions. Sedation for symptom relief: Muscle relaxers or benzodiazepines may make acute pain more tolerable by reducing distress or creating grogginess, even when their direct analgesic effect is minimal. Experience alongside evidence: Years of clinical practice shape decisions when trials do not cleanly match the patient in front of you, a tension between external evidence and bedside judgment we get into in the episode. Practical bedside tradeoffs: Emergency clinicians constantly balance published evidence against feasibility, patient behavior, and comfort, especially when the technically best option is the least likely to work in real life.

High Risk, Low Prevalence: Meningitis

Bacterial meningitis is uncommon but time-critical, with the classic triad present in only about 40% of cases and mortality still around 10% to 30%. Early antibiotics, selective CT before lumbar puncture, and prompt recognition of elevated intracranial pressure drive the first hours of care. Recognizing Bacterial Meningitis Classic triad limits: Fever, neck stiffness, and altered mental status appear together in only about 40% of bacterial meningitis, so absence of the full triad should not lower your suspicion. High-yield symptom pattern: Headache is present in roughly 90% of cases, and about 95% of patients have at least two of the triad features, a more useful bedside frame than waiting for the textbook picture. Meningeal sign pitfalls: Kernig and Brudzinski signs are not sensitive, and jolt accentuation performs too inconsistently to rule out disease. We get into the bedside exam nuance in the episode. Mimics and tempo: Influenza, COVID, endocarditis, spinal epidural abscess, and even carbon monoxide poisoning can resemble meningitis, while immunocompromised patients may have a slower smoldering course. Diagnostics and Lumbar Puncture CSF over serum labs: Blood tests do little to rule meningitis in or out; cerebrospinal fluid is the key study, ideally obtained within 1 hour when it can be done safely. Bacterial CSF profile: Neutrophilic pleocytosis, low glucose, high protein, and elevated opening pressure point toward bacterial meningitis, but a white count under 1000 does not exclude it. Rapid confirmatory testing: Gram stain is highly specific but imperfectly sensitive, while CSF PCR microarray stays useful even after antibiotics and returns far faster than culture. CSF lactate signal: A CSF lactate above 3.5 mmol/L strongly supports bacterial meningitis, although prior antibiotics can blunt the value and make borderline results less reassuring. Selective CT before LP: Head CT before lumbar puncture is reserved for red flags such as elevated ICP, focal deficit, altered mental status, immunocompromise, or new seizure; antibiotics should not wait. We walk through that decision in the chapter. LP contraindication checks: Disseminated intravascular coagulation, platelets under 40,000, and anticoagulant use can make lumbar puncture unsafe, whereas aspirin alone is not considered a meaningful bleeding risk. Early Treatment and ICP Management Immediate empiric antibiotics: Every hour of delay worsens outcomes, so empiric therapy starts with ceftriaxone plus vancomycin while cultures and PCR are pending. Listeria coverage triggers: Older age, diabetes, cancer, and immunosuppression should prompt added Listeria coverage with ampicillin-class therapy or meropenem, a distinction worth hearing in the episode. Adjunctive dexamethasone timing: Dexamethasone should be given just before or with antibiotics, with the clearest benefit seen in pneumococcal meningitis through reduced inflammatory injury. When to add acyclovir: Focal deficits, seizures, marked mental status depression, or immunocompromise should raise concern for HSV encephalitis, where early acyclovir is low-risk and potentially lifesaving. CPP-focused resuscitation: Suspected meningitis with elevated intracranial pressure is a cerebral perfusion problem as much as an infection problem, so target a higher MAP while lowering ICP. First-line ICP lowering: Head-of-bed elevation plus hypertonic saline or mannitol are the headline measures for raised intracranial pressure, with additional escalation paths we cover on the show.

Lit Matters #1: Artificial Intelligence and Human Values

Artificial intelligence in medicine is good at prediction but weak at bedside value judgments. Large language models can draft language fluently, yet treatment recommendations still shift with whose goals are being optimized — patient, clinician, or insurer. AI Predictions and Human Values Probability versus causality: Large language models predict likely next words and can mirror clinical reasoning, but bedside diagnosis depends on cause-and-effect thinking plus patient goals, not probability alone. Stakeholder-dependent recommendations: The same clinical vignette produced different treatment advice when GPT-4 was prompted as a physician, parent, or insurer, highlighting how model output tracks perspective. Utility in medical AI: Utility is the value a model assigns to outcomes, and that value function may reflect the designer or user rather than the patient sitting in front of you. Utility elicitation limits: Eliciting preferences over time is essentially the art of medicine: weighing tests, tradeoffs, and family priorities in ways current AI still handles poorly. We get into that distinction in the episode. Reinforcement learning promise: Reinforcement learning may move AI beyond static probability engines by learning from sequential human decisions, but it is not yet a substitute for clinician judgment. Near-term clinical use: The most credible early wins are patient communication and virtual scribing, whereas autonomous treatment recommendations remain far less reliable in preference-sensitive decisions.

Get the Squeeze You Need - Vasopressor Use in the ED

Vasopressors are not interchangeable, and early agent choice matters in ED shock resuscitation. Norepinephrine and epinephrine are first-line for most shock states, while blood pressure targets, second-agent timing, arterial line decisions, and peripheral pressor safety all change with the physiology in front of you. ED Vasopressor Strategy First-line inopressor choice: Norepinephrine and epinephrine are the default first-line pressors for most shock states because they raise systemic vascular resistance while supporting cardiac output. Anaphylaxis pressor exception: Epinephrine is the first-line vasopressor in anaphylactic shock, with added mast-cell stabilization that makes it more than just a blood pressure drug. Goal-directed pressure targets: Pressors need a defined endpoint: a MAP above 65 is common, but many patients benefit from tracking both MAP and systolic blood pressure against their pathology-specific goal. Second-agent timing: If you have already uptitrated the initial pressor twice, think about adding a second agent rather than reflexively chasing the dose higher. We get into the practical sequencing in the episode. Preferred add-on agents: Vasopressin is the usual second agent in vasodilatory shock, while dobutamine fits low-output states and phenylephrine has a niche when tachycardia makes beta-agonism undesirable. Steroids and dose ceilings: There is no evidence-based vasopressor ceiling in the literature, and stress-dose steroids are reasonable when escalating pressors still are not achieving the hemodynamic goal. Lines Monitoring and Safety Peripheral pressor safety: Peripheral vasopressors are supported for up to 24 hours when the IV is larger than 20 gauge and placed proximal to the antecubital fossa. IO bridge access: Intraosseous access can safely serve as an initial bridge for vasopressor delivery when central access is delayed in a crashing patient. When arterial lines help: Not every patient on vasopressors needs an arterial line; it becomes more useful as titration intensity rises and blood pressure precision starts to matter more. Vasopressin line caveat: Vasopressin is different from catecholamines here: peripheral use is discouraged because extravasation lacks an antidote and digital ischemia is a real complication. Dopamine harms: Dopamine is difficult to titrate and has higher mortality than alternative pressors, plus its diuretic effect can falsely reassure you about renal perfusion. That bedside reasoning is worth hearing in the chapter.

Necessary or Nonsense: Medical Screening in the Suicidal Patient (Part 2)

Suicidal ideation in the ED always requires a medical screening exam, but not every patient needs broad “medical clearance” testing. The real task is identifying medical illness, intoxication, delirium, or cognitive impairment that could be causing or worsening the psychiatric presentation while reducing immediate self-harm risk. Medical Screening in Suicidal Patients Altered mental status first: The first question is whether the patient is altered, because intoxication, infection, metabolic derangement, and delirium can all present as suicidal crisis and change the entire ED workup. Known psychiatric baseline: Patients with established psychiatric disease and a presentation consistent with their usual illness generally do not need routine screening labs just to be declared “medically cleared.” Higher-risk medical subgroups: Older adults, immunosuppressed patients, and anyone with abnormal cognition deserve a broader medical lens; a brief cognitive screen beats relying on “AOx3” alone. Purpose of the exam: The medical screening exam is meant to find illness causing or exacerbating psychiatric symptoms, including uncontrolled hypothyroidism or diabetes linked with depression. We get into the bedside framing in the episode. Retire medical clearance language: “Medically cleared” implies false certainty; a more accurate approach is documenting the patient’s current medical assessment, stability, and any remaining diagnostic limitations. Safety Planning, Holds, and Disposition Contracts for safety: No-suicide contracts do not reduce suicide risk and do not protect clinicians legally; a structured safety plan is the intervention with actual evidence behind it. Formal safety planning: Stanley-Brown and ED-SAFE style plans are cognitive interventions that lower repeat ED visits, suicide attempts, and hospitalization by rehearsing what the patient will do next time. When to use a hold: A legal hold is most defensible when a high-risk patient will not stay, will not engage, or refuses the very interventions meant to reduce self-harm risk. High risk without hold: High risk alone does not automatically mandate involuntary detention if the patient is willing to remain in the ED and participate in risk-reduction steps. Hospitalization limits: Psychiatric hospitalization does not itself reduce future suicide risk, but it may be the only practical option when a patient refuses safety planning, means restriction, or follow-up. That distinction is worth hearing in the chapter. Consult disagreement: If psychiatry recommends discharge while the patient still expresses suicidal ideation, reassess whether meaningful safety planning actually happened and push back when the discharge feels unsafe. Risk Assessment and ED Prevention Risk labels are weak: Low, moderate, and high risk labels are less useful than they sound because future self-harm prediction is imprecise and should not replace bedside intervention. Intervene during the visit: Every patient with suicidal ideation deserves real ED risk reduction, including means restriction, follow-up contact, and linkage to social work, psychiatry, or peer support. Substance use amplifiers: Alcohol and substance use disorders are major suicide risk multipliers, so documenting and addressing them is part of suicide prevention rather than a separate issue. Unclear or doubtful suicidal intent: When the story feels inconsistent, assume there is still an unmet need; careful conversation often uncovers distress, poor communication, or social crisis driving the presentation. ICAR2E framework: The ICAR2E mnemonic organizes suicide care around identifying risk, ensuring safety, reducing danger, and extending care beyond discharge. We walk through how to apply it in the episode.

Lit Matters #2: The AI Future of Emergency Medicine

Artificial intelligence is already embedded in emergency medicine through ECG interpretation, sepsis prediction, lab-pattern recognition, and imaging support. The harder questions are validation, explainability, regulation, and how much clinical reasoning emergency physicians should delegate to models that still confabulate and err. AI in Emergency Medicine Current ED use cases: AI is already operating in emergency care through ECG interpretation, sepsis prediction tools, lab constellation analysis, and image reading, but real-world clinical validation remains thin. Three-stage adoption framework: A practical frame is mapping, measuring, and management: first choose the right problems, then prove performance, then decide how AI actually fits bedside care. Explainability gap in MDM: The central trust problem is whether AI can produce medical decision-making that a clinician can understand, defend, and safely apply when the reasoning is opaque. Confabulation and error risk: Current models can hallucinate and make confident mistakes, which makes unsupervised deployment dangerous in high-stakes emergency decisions. We get into the bedside implications in the episode. Human nuance versus models: Patient care still depends on common-sense context, like recognizing why bilateral upper-extremity injuries make standard discharge-with-crutches advice unrealistic. Regulation and data governance: FDA oversight, privacy protection, and access to the large datasets that train models may determine whether AI scales safely in emergency medicine more than raw model performance alone.

Post-MI Complications

Mechanical and electrical complications after myocardial infarction are rarer in the PCI era, but they remain high-stakes causes of sudden shock, pulmonary edema, and arrest. The dangerous delayed presentations are ventricular free wall rupture, septal rupture, acute ischemic mitral regurgitation, dysrhythmias, and post-MI pericarditis. Electrical Complications After MI AF with ischemic failure: Atrial fibrillation after MI behaves more like AF in acute heart failure than simple rapid AF, so amiodarone or procainamide is preferred over nodal blockers. Standard ACLS plus reperfusion: Post-MI bradyarrhythmias and tachyarrhythmias still follow usual ACLS pathways, but definitive stabilization depends on urgent coronary reperfusion in the cath lab. Reperfusion rhythm clue: Accelerated idioventricular rhythm is a classic reperfusion-associated rhythm after MI rather than an automatic reason to escalate antiarrhythmic therapy, a nuance we get into in the episode. Unstable AF support: When post-MI AF comes with pulmonary edema or hypotension, think positive-pressure ventilation, diuresis, and cardioversion while the ischemic trigger is being fixed. Mechanical Complications After MI Free wall rupture warning: Left ventricular free wall rupture usually appears within the first week after a large infarct and often declares itself with tamponade physiology or sudden pulseless collapse. Echo signs of rupture: Bedside echocardiography is the key test: hemopericardium suggests free wall rupture, while color Doppler across the septum points to a ventricular septal defect. Papillary muscle catastrophe: Papillary muscle rupture causes acute severe mitral regurgitation with flash pulmonary edema, hypotension, and a mobile ruptured muscle head seen on bedside echo. Temporizing ED strategy: These structural lesions are surgical diseases, but emergency management buys time with pressors or inotropy, afterload adjustment, and respiratory support. We walk through the bedside priorities in the chapter. Delayed presentation pattern: Many modern cases present 7 to 10 days after an unrecognized MI, with higher risk in older adults, women, and patients without timely reperfusion. Post-MI Pericarditis Timing Early versus late syndrome: Post-MI pericarditis has two clinically important windows: an early form 2 to 4 days after infarction and a later Dressler-pattern presentation about a week out. Early treatment exception: In the early 2 to 4 day period, avoid NSAIDs and other anti-inflammatory therapy because this form is usually self-limited and management differs from routine pericarditis. Late treatment approach: Later post-MI pericarditis is treated more like standard pericarditis, with NSAIDs, colchicine, or steroids depending on the clinical context. Essential imaging check: Transthoracic echo matters in any suspected post-MI pericarditis because the complication that changes urgency is a pericardial effusion or tamponade physiology.

Lit Matters #3: The Application of AI in Emergency Medicine (Paper 4/4)

AI-assisted chest x-ray interpretation improves emergency-relevant image reading most for nonradiologists, with smaller gains for radiology residents. In emergency medicine, the clearest current AI win may be as a secondary reader for pneumothorax, pleural effusion, consolidation, and pulmonary nodules when 24/7 attending radiology coverage is limited. AI for Emergency Chest Radiographs Secondary reader role: Chest x-ray AI fits best as a secondary reader in the ED because image interpretation has a pathology-based ground truth, making accuracy more clinically useful than many prediction tools. Nonradiologist performance gains: Nonradiology physicians showed the biggest lift with AI, including pneumothorax AUC improving from 0.846 to 0.974 and sizable sensitivity gains across all four target findings. Nodule detection signal: Pulmonary nodules were the standout use case, with nonradiologists gaining markedly on detection and AI itself reaching an AUC of 0.931 for recommending follow-up CT. We get into why that matters operationally in the episode. Resident versus nonradiologist effect: Radiology residents also improved with AI, but the gains were consistently smaller, suggesting the tool can narrow part of the gap for less imaging-trained clinicians rather than replace expert overreads. Implementation friction points: Real-world adoption is less about whether the model can classify films and more about who owns the first read, discrepancy workflow, liability, and billing when AI enters the loop. Human judgment remains central: AI still lacks clinical common sense, so chest radiograph outputs need bedside interpretation in context; augmentation is the message, not substitution of emergency physicians or radiologists.